Visual outcome in cats with hypertensive chorioretinopathy
Purpose To investigate factors associated with long‐term visual outcome in cats with hypertensive chorioretinopathy. Animals studied Eighty‐eight client‐owned cats diagnosed with hypertensive chorioretinopathy. Procedure Medical records from cats with systemic hypertension and associated retinal les...
Gespeichert in:
| Veröffentlicht in: | Veterinary ophthalmology 2019-03, Vol.22 (2), p.161-167 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 167 |
|---|---|
| container_issue | 2 |
| container_start_page | 161 |
| container_title | Veterinary ophthalmology |
| container_volume | 22 |
| creator | Young, Whitney M Zheng, Chaowen Davidson, Michael G Westermeyer, Hans D |
| description | Purpose
To investigate factors associated with long‐term visual outcome in cats with hypertensive chorioretinopathy.
Animals studied
Eighty‐eight client‐owned cats diagnosed with hypertensive chorioretinopathy.
Procedure
Medical records from cats with systemic hypertension and associated retinal lesions were reviewed.
Results
Most cats (61%) were blind in both eyes at presentation. Presence of menace response at last follow‐up evaluation was positively correlated with presence of menace response at presentation (P = .0025), time to complete retinal reattachment (P < .0001), and gender (P = .0137). Seventy‐six of 132 eyes (57.6%) that were blind at presentation regained some vision following treatment. At the time of last evaluation, 101/176 eyes (60%) had a positive menace response, while 34/46 (74%) eyes with a follow‐up of >6 months had a positive menace response. Eyes that had a menace response at presentation were 17 and 37 times more likely to have a menace response at last examination compared to eyes blind for less than 2 weeks and eyes blind greater than 2 weeks, respectively. Female cats were overrepresented (62.5% of cases), and male cats were 4.2 times more likely to be visual at time of last examination compared to female cats.
Conclusions
With treatment, the prognosis for long‐term vision in cats with hypertensive chorioretinopathy, even following complete retinal detachment, is good. |
| doi_str_mv | 10.1111/vop.12575 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2027070059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2027070059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3255-ff0265e983dc14716cdb155097cd20c2779f9bf6578cb34f76a0d7da6f1bc92c3</originalsourceid><addsrcrecordid>eNp1kL1OwzAURi0EoqUw8AIoIwxpbSe2GzZU8SdVKgN0tRzHVoySONhOq7w9gZRu3OW7w9EZDgDXCM7RcIudbecIE0ZOwBSlNIkJxunp8Ud0Ai68_4QQJgSyczDBGaWMJcspuN8a34kqsl2QtlaRaSIpgo_2JpRR2bfKBdV4s1ORLK0z1qlgGtuKUPaX4EyLyqurw87Ax9Pj--olXm-eX1cP61gmmJBYa4gpUdkyKSRKGaKyyBEhMGOywFBixjKd5ZoStpR5kmpGBSxYIahGucywTGbgdvS2zn51ygdeGy9VVYlG2c5zDDGDDEKSDejdiEpnvXdK89aZWrieI8h_UvEhFf9NNbA3B22X16o4kn9tBmAxAntTqf5_E99u3kblN6YPcz8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2027070059</pqid></control><display><type>article</type><title>Visual outcome in cats with hypertensive chorioretinopathy</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Young, Whitney M ; Zheng, Chaowen ; Davidson, Michael G ; Westermeyer, Hans D</creator><creatorcontrib>Young, Whitney M ; Zheng, Chaowen ; Davidson, Michael G ; Westermeyer, Hans D</creatorcontrib><description>Purpose
To investigate factors associated with long‐term visual outcome in cats with hypertensive chorioretinopathy.
Animals studied
Eighty‐eight client‐owned cats diagnosed with hypertensive chorioretinopathy.
Procedure
Medical records from cats with systemic hypertension and associated retinal lesions were reviewed.
Results
Most cats (61%) were blind in both eyes at presentation. Presence of menace response at last follow‐up evaluation was positively correlated with presence of menace response at presentation (P = .0025), time to complete retinal reattachment (P < .0001), and gender (P = .0137). Seventy‐six of 132 eyes (57.6%) that were blind at presentation regained some vision following treatment. At the time of last evaluation, 101/176 eyes (60%) had a positive menace response, while 34/46 (74%) eyes with a follow‐up of >6 months had a positive menace response. Eyes that had a menace response at presentation were 17 and 37 times more likely to have a menace response at last examination compared to eyes blind for less than 2 weeks and eyes blind greater than 2 weeks, respectively. Female cats were overrepresented (62.5% of cases), and male cats were 4.2 times more likely to be visual at time of last examination compared to female cats.
Conclusions
With treatment, the prognosis for long‐term vision in cats with hypertensive chorioretinopathy, even following complete retinal detachment, is good.</description><identifier>ISSN: 1463-5216</identifier><identifier>EISSN: 1463-5224</identifier><identifier>DOI: 10.1111/vop.12575</identifier><identifier>PMID: 29667738</identifier><language>eng</language><publisher>England</publisher><subject>Amlodipine - therapeutic use ; Animals ; Antihypertensive Agents - therapeutic use ; Benzazepines - therapeutic use ; Blindness - veterinary ; cat ; Cat Diseases - drug therapy ; Cats ; Choroid Diseases - drug therapy ; Choroid Diseases - etiology ; Choroid Diseases - veterinary ; Female ; Hypertension - complications ; Hypertension - drug therapy ; Hypertension - veterinary ; hypertensive chorioretinopathy ; hypertensive retinopathy ; Hypertensive Retinopathy - drug therapy ; Hypertensive Retinopathy - etiology ; Hypertensive Retinopathy - veterinary ; Male ; Prognosis ; retina ; systemic hypertension ; Treatment Outcome ; vision ; Vision, Ocular</subject><ispartof>Veterinary ophthalmology, 2019-03, Vol.22 (2), p.161-167</ispartof><rights>2018 American College of Veterinary Ophthalmologists</rights><rights>2018 American College of Veterinary Ophthalmologists.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3255-ff0265e983dc14716cdb155097cd20c2779f9bf6578cb34f76a0d7da6f1bc92c3</citedby><cites>FETCH-LOGICAL-c3255-ff0265e983dc14716cdb155097cd20c2779f9bf6578cb34f76a0d7da6f1bc92c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fvop.12575$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fvop.12575$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29667738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Young, Whitney M</creatorcontrib><creatorcontrib>Zheng, Chaowen</creatorcontrib><creatorcontrib>Davidson, Michael G</creatorcontrib><creatorcontrib>Westermeyer, Hans D</creatorcontrib><title>Visual outcome in cats with hypertensive chorioretinopathy</title><title>Veterinary ophthalmology</title><addtitle>Vet Ophthalmol</addtitle><description>Purpose
To investigate factors associated with long‐term visual outcome in cats with hypertensive chorioretinopathy.
Animals studied
Eighty‐eight client‐owned cats diagnosed with hypertensive chorioretinopathy.
Procedure
Medical records from cats with systemic hypertension and associated retinal lesions were reviewed.
Results
Most cats (61%) were blind in both eyes at presentation. Presence of menace response at last follow‐up evaluation was positively correlated with presence of menace response at presentation (P = .0025), time to complete retinal reattachment (P < .0001), and gender (P = .0137). Seventy‐six of 132 eyes (57.6%) that were blind at presentation regained some vision following treatment. At the time of last evaluation, 101/176 eyes (60%) had a positive menace response, while 34/46 (74%) eyes with a follow‐up of >6 months had a positive menace response. Eyes that had a menace response at presentation were 17 and 37 times more likely to have a menace response at last examination compared to eyes blind for less than 2 weeks and eyes blind greater than 2 weeks, respectively. Female cats were overrepresented (62.5% of cases), and male cats were 4.2 times more likely to be visual at time of last examination compared to female cats.
Conclusions
With treatment, the prognosis for long‐term vision in cats with hypertensive chorioretinopathy, even following complete retinal detachment, is good.</description><subject>Amlodipine - therapeutic use</subject><subject>Animals</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Benzazepines - therapeutic use</subject><subject>Blindness - veterinary</subject><subject>cat</subject><subject>Cat Diseases - drug therapy</subject><subject>Cats</subject><subject>Choroid Diseases - drug therapy</subject><subject>Choroid Diseases - etiology</subject><subject>Choroid Diseases - veterinary</subject><subject>Female</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - veterinary</subject><subject>hypertensive chorioretinopathy</subject><subject>hypertensive retinopathy</subject><subject>Hypertensive Retinopathy - drug therapy</subject><subject>Hypertensive Retinopathy - etiology</subject><subject>Hypertensive Retinopathy - veterinary</subject><subject>Male</subject><subject>Prognosis</subject><subject>retina</subject><subject>systemic hypertension</subject><subject>Treatment Outcome</subject><subject>vision</subject><subject>Vision, Ocular</subject><issn>1463-5216</issn><issn>1463-5224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL1OwzAURi0EoqUw8AIoIwxpbSe2GzZU8SdVKgN0tRzHVoySONhOq7w9gZRu3OW7w9EZDgDXCM7RcIudbecIE0ZOwBSlNIkJxunp8Ud0Ai68_4QQJgSyczDBGaWMJcspuN8a34kqsl2QtlaRaSIpgo_2JpRR2bfKBdV4s1ORLK0z1qlgGtuKUPaX4EyLyqurw87Ax9Pj--olXm-eX1cP61gmmJBYa4gpUdkyKSRKGaKyyBEhMGOywFBixjKd5ZoStpR5kmpGBSxYIahGucywTGbgdvS2zn51ygdeGy9VVYlG2c5zDDGDDEKSDejdiEpnvXdK89aZWrieI8h_UvEhFf9NNbA3B22X16o4kn9tBmAxAntTqf5_E99u3kblN6YPcz8</recordid><startdate>201903</startdate><enddate>201903</enddate><creator>Young, Whitney M</creator><creator>Zheng, Chaowen</creator><creator>Davidson, Michael G</creator><creator>Westermeyer, Hans D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201903</creationdate><title>Visual outcome in cats with hypertensive chorioretinopathy</title><author>Young, Whitney M ; Zheng, Chaowen ; Davidson, Michael G ; Westermeyer, Hans D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3255-ff0265e983dc14716cdb155097cd20c2779f9bf6578cb34f76a0d7da6f1bc92c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Amlodipine - therapeutic use</topic><topic>Animals</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Benzazepines - therapeutic use</topic><topic>Blindness - veterinary</topic><topic>cat</topic><topic>Cat Diseases - drug therapy</topic><topic>Cats</topic><topic>Choroid Diseases - drug therapy</topic><topic>Choroid Diseases - etiology</topic><topic>Choroid Diseases - veterinary</topic><topic>Female</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - veterinary</topic><topic>hypertensive chorioretinopathy</topic><topic>hypertensive retinopathy</topic><topic>Hypertensive Retinopathy - drug therapy</topic><topic>Hypertensive Retinopathy - etiology</topic><topic>Hypertensive Retinopathy - veterinary</topic><topic>Male</topic><topic>Prognosis</topic><topic>retina</topic><topic>systemic hypertension</topic><topic>Treatment Outcome</topic><topic>vision</topic><topic>Vision, Ocular</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Young, Whitney M</creatorcontrib><creatorcontrib>Zheng, Chaowen</creatorcontrib><creatorcontrib>Davidson, Michael G</creatorcontrib><creatorcontrib>Westermeyer, Hans D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Veterinary ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Young, Whitney M</au><au>Zheng, Chaowen</au><au>Davidson, Michael G</au><au>Westermeyer, Hans D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Visual outcome in cats with hypertensive chorioretinopathy</atitle><jtitle>Veterinary ophthalmology</jtitle><addtitle>Vet Ophthalmol</addtitle><date>2019-03</date><risdate>2019</risdate><volume>22</volume><issue>2</issue><spage>161</spage><epage>167</epage><pages>161-167</pages><issn>1463-5216</issn><eissn>1463-5224</eissn><abstract>Purpose
To investigate factors associated with long‐term visual outcome in cats with hypertensive chorioretinopathy.
Animals studied
Eighty‐eight client‐owned cats diagnosed with hypertensive chorioretinopathy.
Procedure
Medical records from cats with systemic hypertension and associated retinal lesions were reviewed.
Results
Most cats (61%) were blind in both eyes at presentation. Presence of menace response at last follow‐up evaluation was positively correlated with presence of menace response at presentation (P = .0025), time to complete retinal reattachment (P < .0001), and gender (P = .0137). Seventy‐six of 132 eyes (57.6%) that were blind at presentation regained some vision following treatment. At the time of last evaluation, 101/176 eyes (60%) had a positive menace response, while 34/46 (74%) eyes with a follow‐up of >6 months had a positive menace response. Eyes that had a menace response at presentation were 17 and 37 times more likely to have a menace response at last examination compared to eyes blind for less than 2 weeks and eyes blind greater than 2 weeks, respectively. Female cats were overrepresented (62.5% of cases), and male cats were 4.2 times more likely to be visual at time of last examination compared to female cats.
Conclusions
With treatment, the prognosis for long‐term vision in cats with hypertensive chorioretinopathy, even following complete retinal detachment, is good.</abstract><cop>England</cop><pmid>29667738</pmid><doi>10.1111/vop.12575</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1463-5216 |
| ispartof | Veterinary ophthalmology, 2019-03, Vol.22 (2), p.161-167 |
| issn | 1463-5216 1463-5224 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2027070059 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Amlodipine - therapeutic use Animals Antihypertensive Agents - therapeutic use Benzazepines - therapeutic use Blindness - veterinary cat Cat Diseases - drug therapy Cats Choroid Diseases - drug therapy Choroid Diseases - etiology Choroid Diseases - veterinary Female Hypertension - complications Hypertension - drug therapy Hypertension - veterinary hypertensive chorioretinopathy hypertensive retinopathy Hypertensive Retinopathy - drug therapy Hypertensive Retinopathy - etiology Hypertensive Retinopathy - veterinary Male Prognosis retina systemic hypertension Treatment Outcome vision Vision, Ocular |
| title | Visual outcome in cats with hypertensive chorioretinopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T10%3A59%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Visual%20outcome%20in%20cats%20with%20hypertensive%20chorioretinopathy&rft.jtitle=Veterinary%20ophthalmology&rft.au=Young,%20Whitney%20M&rft.date=2019-03&rft.volume=22&rft.issue=2&rft.spage=161&rft.epage=167&rft.pages=161-167&rft.issn=1463-5216&rft.eissn=1463-5224&rft_id=info:doi/10.1111/vop.12575&rft_dat=%3Cproquest_cross%3E2027070059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2027070059&rft_id=info:pmid/29667738&rfr_iscdi=true |